Answer
Concomitant use of lanadelumab and C1 esterase inhibitor rescue medication produces an additive effect on the lanadelumab-cHMWK response, based on their mechanisms of action.
Sources for this answer
- TAKHZYRO 300 mg solution for injection in pre-filled syringeTakeda UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 8Document updated
Sources checked